Answers are grounded in this paper and cite their sources.
Purpose: Commercial clinical decision support software (CDSS) may overestimate the severity of drug-drug interactions (DDI) because of their broad application; whereas, clinicians with knowledge of the patient should be able to better assess DDI severity. The purpose of this project was to compare DDI severity for clinician opinion in the context of the patient's clinical status to the severity of proprietary databases.
No takes yet. Share an insight, caveat, or question.
Armahizer et al. (2012) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: